Topcon Medical Systems has introduced a new computerized lensmeter (CL-300 Computerized Lensmeter) in
U.S and Latin American markets.
Author: ModernMedecine
Topcon introduces new device, celebrates 80 years
Topcon Medical Systems has introduced a new computerized lensmeter (CL-300 Computerized Lensmeter) in
U.S and Latin American markets.
Fluocinolone inserts helpful in diabetic macular edema
NEW YORK (Reuters Health) – In patients with diabetic macular edema (DME), fluocinolone acetonide
(FAc) vitreous inserts worked well for up to three years in a recent study.
Retinal detachment risk from cataract surgery falls
NEW YORK (Reuters Health) – The risk of a person’s retina detaching after having a cataract removed is
dropping, says a new study published July 9 in the Archives of Ophthalmology.
As lawsuits climb, J&J may have new hip trauma
CHICAGO (Reuters) – Johnson & Johnson faces a potentially more damaging and costly sequel
to the $3 billion recall of its ASR all-metal artificial hips two years ago, one of the most expensive medical
device failures in U.S. history.
Bevacizumab shows no benefit in advanced-stage AMD
NEW YORK (Reuters Health) – Intravitreal bevacizumab does not benefit patients with advanced
neovascular age-related macular degeneration (AMD) and very poor vision, according to a small study.
Smartphones may aid eye diagnoses in the ER
NEW YORK (Reuters Health) – Sending patient images to ophthalmologists via smartphone may be an option
for emergency room doctors looking to make a quick eye-related diagnosis, a new study suggests.
VEGF inhibitors for macular degeneration not tied to stroke
NEW YORK (Reuters Health) – Vascular endothelial growth factor (VEGF) inhibitors used for age-related
macular degeneration did not increase patients’ risk of stroke in a population-based study in Canada.
Growth hormone tied to higher eye pressure in kids
NEW YORK (Reuters Health) – Short children treated with growth hormone may have slightly higher ocular
pressure compared with children not on the therapy, according to a small study from Israel.
Phenylephrine prevents, treats floppy iris in cataract surgery
NEW YORK (Reuters Health) – Researchers have proposed a solution to the "floppy iris"
problem that plagues some patients during cataract surgery.
Bevacizumab monotherapy shows potential for some patients with ROP
Bevacizumab (Avastin, Genentech) monotherapy for zone I retinopathy of prematurity (ROP) might have
potential for treating pre-term infants who are in phase II of the pathogenesis of ROP.
IFN combo may improve healing of corneal intraepithelial neoplasia
NEW YORK (Reuters Health) – Conjunctival and corneal intraepithelial neoplasia may resolve faster with
retinoic acid plus topical interferon alfa-2b than with interferon alone, Australian researchers
suggest.
Shrapnel, not blasts from fireworks, injures eyes
NEW YORK (Reuters Health) – Just in time for Independence Day in the U.S., a new study shows for the
first time how fireworks actually damage eyeballs – and it’s not by the force of the blast itself.
Ophthalmic Tech’s Community of Practice
iTech provides educational presentations for ophthalmic and optometric technicians, offering new
learning skills, clinical tips, and instructional case studies that will help technicians work effectively with
their doctors to enhance the practice.
Statins might curb risk of open-angle glaucoma
NEW YORK (Reuters Health) – A study in patients with hyperlipidemia suggests statins may also protect
against open-angle glaucoma (OAG).
Approach yields stability, predictability
A minimally invasive technique for the correction of refractive errors has good refractive
predictability, is safe and effective, and has excellent stability up to 1 year postoperatively.
Alternative LASIK procedure a success
Results from the first clinical trial of myopic LASIK with a new advanced wavefront-guided system are
excellent and indicate the procedure is an acceptable and efficacious alternative to conventional
LASIK.
Anti-platelet-derived growth factor subunit B/anti-vascular endothelial growth factor benefits wet age-related macular degeneration
Recently released topline results from a phase Iib clinical trial of treatment for neovascular
age-related macular degeneration show significantly greater improvement in visual acuity among patients receiving
combination therapy with Fovista, a…
Congenital cataract still a challenge
Advances in ophthalmic surgery, especially vitreous suction-cutting devices, have made the treatment
of congenital cataracts in the pediatric poulation easier and more effective.
Continuing medical education a balancing act
Continuing medical education is essential for the provision of good medical care.